Craft
Natera

Natera

Laboratory Distribution Partners

100

Q1, 2022

Revenue

$625.5 M

FY, 2021

Market Capitalization

$4.6 B

2022-09-19

Natera Summary

Company summary

Overview
Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. It develops a cell-free DNA (cfDNA) testing platform, dedicated to oncology, women’s health, and organ health.
Type
Public
Founded
2004
HQ
Austin, TX, US | view all locations
Website
https://www.natera.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Steve Chapman

    Steve Chapman, Chief Executive Officer and Director

  • Mike Brophy

    Mike Brophy, Chief Financial Officer

  • Robert Schueren

    Robert Schueren, Chief Operating Officer

  • Olesya Anisimova

    Olesya Anisimova, Chief Accounting Officer

Operating MetricsView all

Covered Lives

230M
7.5%

FY, 2021

Tests

489.3K
40.5%

Q1, 2022

Facilities Leased, sq. ft.

272K

FY, 2021

LocationsView all

2 locations detected

  • Austin, TX HQ

    United States

    13011 McCallen Pass a 100

  • San Carlos, CA

    United States

    201 Industrial Rd

Natera Financials

Summary financials

Revenue (Q2, 2022)
$198.2M
Gross profit (Q2, 2022)
$89.0M
Net income (Q2, 2022)
($145.2M)
Cash (Q2, 2022)
$91.3M
EBIT (Q2, 2022)
($143.1M)
Enterprise value
$4.9B

Footer menu